Strategic expansion ProCure operates a proton therapy center in Somerset, NJ, as the first in the NJ/NY tri-state region, highlighting opportunity to partner on expansion initiatives or referrals within dense healthcare markets and neighboring states.

Advanced tech leverage With Pencil Beam Scanning PBS as their core capability, there is potential to upsell complementary imaging, treatment planning, or post-treatment analytics solutions that optimize proton therapy workflows and outcomes.

Patient volume potential Having treated over 7,000 patients and serving a niche cancer treatment modality, there may be demand for patient navigation, advocacy, and payer collaboration services to improve access and throughput.

Financial health signals Revenue in the lower tens of millions with substantial funding indicates capacity for investment in ancillary services, equipment upgrades, or research partnerships to expand treatment options and clinical trials.

Market positioning Being an early proton therapy provider in the region suggests opportunities to collaborate on education, marketing partnerships, and referral networks with larger cancer centers and upleveling community awareness programs.